About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Serotonin Syndrome in Patients Using Triptans With Antidepressants

by Chrisy Ngilneii on February 28, 2018 at 6:30 PM
Font : A-A+

Serotonin Syndrome in Patients Using Triptans With Antidepressants

Simultaneous use of triptans for migraine with antidepressants may result in only a low risk of developing serotonin syndrome, according to recent research at the University of Florida.

The study suggests that an advisory from the U.S. Food and Administration on that risk should be reconsidered.

Advertisement


Why The Research Is Interesting: The FDA issued an advisory in 2006 about the risk of serotonin syndrome associated with concomitant use (at the same time) of triptan antimigraine drugs and selective serotonin reuptake inhibitor (SSRIs) or selective norepinephrine reuptake inhibitor (SNRIs) antidepressants. The severity of serotonin syndrome can vary, with symptoms including rapid heart rate, unstable blood pressure, vomiting and diarrhea, but the condition also can be fatal. Depression and migraine are disabling conditions that frequently occur together but the risk of serotonin syndrome in patients prescribed both antidepressants and triptans is unknown.

Who and When: 19,017 patients prescribed both triptans and antidepressants in the greater Boston area from 2001 through 2014 based on electronic health record data.
Advertisement

What (Study Measures):  Prescriptions for both triptan and antidepressants (exposure); incidence (rate of new cases) of serotonin syndrome.

How (Study Design): This was an observational study. Researchers were not intervening for purposes of the study and cannot control for all the natural differences that could explain the study results.

Results: Estimates suggest the incidence of serotonin syndrome was 0 to 4 cases per 10,000 person years (a unit of time for different people observed over different periods of time); the proportion of patients with triptan and antidepressant prescriptions was stable during the study and ranged from 21 percent to 29 percent.

Study Limitations: The quality of medical documentation can vary and it is possible clinicians who did not recognize serotonin syndrome might have used other diagnostic codes.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Cochlear Implants may Consequently Drive Hearing Loss
E-cigarettes Use Linked to Erectile Dysfunction
Memory Loss - Can it be Recovered?
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Fibromyalgia Carcinoid Tumors Antidepressants Food and Mood Antidepressants Use during Pregnancy 

Recommended Reading
Antidepressants Use during Pregnancy
Depression is common during pregnancy and antidepressants are usually prescribed to overcome it. Is ...
Premenstrual Syndrome
Premenstrual syndrome or PMS is a medical condition characterized by a range of physical and ......
Drugs Causing Weight Gain
Medications are among the lesser-known yet common causes of weight gain. Switching over to a lesser ...
Food and Mood
People are more alert when their brains are producing the neurotransmitters dopamine and ......
Carcinoid Tumors
Carcinoid tumors is a benign tumor that results in carcinoid syndrome. Only 8 to 10% of all carcinoi...
Fibromyalgia
Fibromyalgia (FM) is a chronic health condition charecterized by widespread pain and stiffness in th...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use